Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

331 results
Display

Current trends in minimally invasive surgery for benign prostatic hyperplasia

Choo MS, Son H

The prevalence of benign prostatic hyperplasia (BPH) is rising with Korea becoming an aging society. As patients age, their comorbidities and the risks associated with anesthesia increase. Recently, there has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction

Ahn ST, Lee DH, Jeong HG, Kim JW, Oh MM, Park HS, Moon DG

PURPOSE: The primary aim of this study was to assess treatment persistence with a fixed-dose combination (FDC) of tadalafil (5 mg) and tamsulosin (0.4 mg). This study also evaluated the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia

Chung JS, Seo WI, Oh CK, Kim SC, Park MC, Park SH, Yu J, Lee CH, Kim W, Park TY, Min KS, Chung JI

PURPOSE: Preoperative use of 5α-reductase inhibitors (5ARIs) may cause fibrosis of the prostate tissue and reduce the efficiency of thulium laser surgery for treating benign prostate hyperplasia (BPH). Thus, we...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Albizzia julibrissin Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase Type 2 – Androgen Receptor Pathway

Hong GL, Kim HT, Park SR, Lee NH, Ryu KA, Kim TW, Song GY, Jung JY

Albizzia julibrissin (AJ) is an herbal medicine that shows low toxicity, promotes promoting blood circulation and mitigates the inflammation and has mild side effects. Benign prostate hyperplasia (BPH) is one...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is transurethral needle ablation of prostate out of fashion? Outcomes of single session office-based transurethral needle ablation of prostate in patients with symptomatic benign prostatic hyperplasia

Law YX, Chen WJ, Shen L, Chua WJ

PURPOSE: Transurethral needle ablation (TUNA) is a minimally invasive procedure for the treatment of symptomatic benign prostatic hyperplasia (BPH). Compared to transurethral resection of the prostate (TURP), office-based TUNA is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
It's Time to Take Advantage of Robotic Assisted Simple Prostatectomy in Large Benign Prostatic Hyperplasia

Kim M, Shin YS, KSSMA RASP group

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Relationships between Thyroid Hormone Levels and Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia

Lee JH, Park YW, Lee SW

PURPOSE: We examined the association between thyroid hormone and lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: A total of 5,708 middle aged men were included. LUTS/BPH were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prostate Artery Embolization: Treatment of Symptomatic Benign Prostatic Hyperplasia

Hwang JH, Park SW

Prostatic artery embolization (PAE) is an emerging treatment option for lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). PAE is a minimally invasive technique and provides good...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia

Shin YS, Karna KK, Choi BR, Park JK

Finasteride is primarily used to treat benign prostatic hyperplasia (BPH) and male androgenetic alopecia (MAA). Five-alpha reductase inhibitors (5α-RIs) could induce male sexual dysfunction due to their effects on testosterone...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Analysis of Present Status for Surgery of Benign Prostatic Hyperplasia in Korea Using Nationwide Healthcare System Data

Jeon BJ, Chung H, Bae JH, Jung H, Lee JG, Choi H

PURPOSE: There are no established statistical data available for the comparison of different surgical methods adopted for the resection of benign prostatic hyperplasia (BPH). This study investigates the present status...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects

Kim WT, Yun SJ, Kim WJ

Prostate cancer (CaP) is the most common cancer diagnosed among men in the United States and the fifth most common cancer among men in Korea. Unfortunately, the early stages of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Analysis of Trends of 3 Major Benign Prostatic Hyperplasia Surgery in the Last 5 Years

Min SK, Kim BH, Choi KB, Cho IC

PURPOSE: The goal of this study is to analyze the trends in surgical management of Benign prostatic hyperplasia (BPH) in Korea during the last 5 years from 2014 to 2018. MATERIALS...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of Bladder Neck Stiffness on Lower Urinary Tract Symptoms in Patient With Benign Prostatic Hyperplasia

Kwon JK, Jung HD, Cho KS

PURPOSE: We evaluated the impact of bladder neck stiffness on lower urinary tract symptoms in the patient with benign prostatic hyperplasia using elastography. MATERIALS AND METHODS: A total of 384 patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Systematic Review of the Efficacy and Safety of Minimally Invasive Surgical Treatments in Benign Prostatic Hyperplasia

Lee MH, Shin YS, Kam SC

Lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH) has conventionally treated by transurethral resection of the prostate (TURP) or open simple prostatectomy. TURP has historically been associated with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Early Experiences of a Minimal Invasive Intra-Prostatic Implant, Prostatic Urethral Lift for Benign Prostatic Hyperplasia Treatment in Korea

Yang J, Shin D, Sung J, Cho S, Kang S, Jeong HC, Choi SW, Bae WJ, Kim SW

PURPOSE: As a minimal invasive device for benign prostatic hyperplasia (BPH) treatment, prostatic urethral lift (PUL) is widely accepted worldwide but not widely used in Korea. We investigated the one-year...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inhibitory effects of Pycnogenol®, a pine bark extract, in a rat model of testosterone propionate-induced benign prostatic hyperplasia

Ko JW, Park SW, Shin NR, Kim WI, Kim JC, Shin IS, Shin DH

Benign prostate hyperplasia (BPH) is a male reproductive disease that has gained increasing importance in recent years. The present study investigated whether Pycnogenol® (PYC), a standardized French maritime pine bark...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Alpha-Blockers on Patients with Benign Prostatic Hyperplasia with Inflammatory Cells in the Prostatic Fluid

Seo YM, Kim HJ

PURPOSE: To determine if alpha-blocker monotherapy is effective on patients with benign prostatic hyperplasia (BPH) and prostatic inflammation. MATERIALS AND METHODS: Patients who were admitted for the treatment of lower urinary...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Add-on Therapy With the α-Blockers Tamsulosin and Naftopidil Improves Voiding Function by Enhancing Neuronal Activity in Prostatic Hyperplasia Rats

Ko IG, Hwang L, Jin JJ, Kim SH, Han JH, Jeon JW, Cho ST

PURPOSE: Benign prostatic hyperplasia (BPH) impacts quality of life in men by causing lower urinary tract symptoms. α1-Adrenoceptor (α1-AR) blockers improve lower urinary tract symptoms. We investigated the efficacy of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Outcome of 980 nm diode laser vaporization for benign prostatic hyperplasia: A prospective study

Mithani MH, Khalid SE, Khan SA, Sharif I, Awan AS, Mithani S, Majeed I

PURPOSE: To evaluate the initial experience and outcome of photo-selective vaporization of the prostate (PVP) for benign prostatic hyperplasia (BPH) in Pakistan with the use of a 980 nm diode...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5α-reductase and androgen receptor expression in rats

Hwangbo H, Kwon DH, Choi EO, Kim MY, Ahn KI, Ji SY, Kim JS, Kim KI, Park NJ, Kim BH, Kim GY, Hong SH, Park C, Jeong JS, Choi YH

BACKGROUND/OBJECTIVES: Benign prostatic hypertrophy (BPH) is a major cause of abnormal overgrowth of the prostate mainly in the elderly. Corni Fructus has been reported to be effective in the prevention...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr